The provided search results cover:
None of these sources mention "YGR161W-C Antibody" or any related nomenclature.
The identifier "YGR161W-C" does not align with standard antibody naming conventions (e.g., INN/USAN, IgG subclass, or target-specific formats like anti-PD-1).
Yeast genome nomenclature uses "YGR161W" to denote chromosomal coordinates for genes, but this does not correspond to antibody terminology.
No clinical or preclinical studies referencing this compound appear in PubMed, clinical trial registries, or industry databases.
The Antibody Society’s therapeutic antibody database ( ) lists ~200 approved/reviewed antibodies (e.g., Retifanlimab, Regdanvimab) but does not include this entity.
| Step | Action | Purpose |
|---|---|---|
| 1 | Verify nomenclature | Confirm if "YGR161W-C" refers to a gene product, hypothetical antibody, or typographical error. |
| 2 | Consult specialized databases | Search the Universal Protein Resource (UniProt), DrugBank, or Patent Commons for unpublished data. |
| 3 | Contact developers | Reach out to academic/commercial entities listed in antibody catalogs (e.g., Abcam, Thermo Fisher). |
YGR161W-C (also annotated as RTS3/YGR161W-C in some databases) represents a yeast gene encoding a protein involved in DNA-binding functions . The significance of YGR161W-C lies in its potential role in transcriptional regulation networks. Based on genomic studies, this protein appears in experimental contexts where researchers investigate protein-DNA interactions, particularly in techniques designed to identify binding sites of transcription factors. Understanding YGR161W-C is valuable for researchers studying fundamental aspects of gene regulation and chromatin interactions in yeast models, which often translate to insights applicable to higher eukaryotes.
Several experimental approaches can effectively detect YGR161W-C binding sites:
Chromatin Immunoprecipitation (ChIP-chip): This method allows identification of binding sites by using YGR161W-C antibodies to immunoprecipitate the protein along with its bound DNA fragments, which are then hybridized to microarrays . This technique provides genome-wide binding profiles and has been successfully applied to similar transcription factors.
Ty5 Transposon "Calling Cards" Method: A novel approach described in the literature where DNA-binding proteins fused with Sir4 direct the insertion of the Ty5 retrovirus-like transposon near their binding sites. The genomic locations of these insertions can then be mapped to identify binding sites . This method has successfully identified targets of well-characterized transcription factors like Gal4 and Gcn4.
Yeast One-Hybrid Screens: Particularly useful when starting with a DNA sequence of interest and seeking to identify proteins (potentially including YGR161W-C) that bind to it .
Each method offers distinct advantages depending on experimental priorities (genome-wide coverage versus focused analysis of specific regions).
Verifying antibody specificity is critical for reliable results in immunoprecipitation experiments. For YGR161W-C antibodies, consider these validation approaches:
Western blot with positive and negative controls: Test the antibody against samples with known expression levels of YGR161W-C, including wild-type strains and YGR161W-C deletion mutants.
Epitope-tagged validation: Compare immunoprecipitation results between native YGR161W-C and an epitope-tagged version (e.g., myc-tagged YGR161W-C) using both the YGR161W-C antibody and a commercial anti-tag antibody . Correlation between results supports antibody specificity.
Competitive blocking: Pre-incubate the antibody with purified YGR161W-C protein before immunoprecipitation. Reduced signal indicates specific binding.
Sequential ChIP experiments: Perform ChIP with the YGR161W-C antibody followed by another ChIP with a different antibody targeting a known interaction partner to confirm co-localization at genuine binding sites.
Document these validation steps thoroughly, as they will strengthen the credibility of subsequent experimental findings.
Contradictory results between different methods for identifying YGR161W-C binding sites can provide valuable insights rather than merely representing experimental error. Consider this structured approach to resolve discrepancies:
Examine methodological biases:
Cross-validation analysis:
Biological context consideration:
Analyze discrepancies in light of chromatin state data
Consider if differences correlate with specific functional categories of genes
Examine temporal aspects of binding (constitutive vs. condition-specific)
Statistical refinement:
Contradictions often emerge from the complementary strengths and limitations of different methods, collectively providing a more complete picture of the biological reality.
Enhancing sensitivity and specificity in YGR161W-C chromatin studies requires optimization at multiple levels:
Crosslinking optimization:
Test multiple formaldehyde concentrations (0.5-3%)
Explore dual crosslinking with both formaldehyde and protein-specific crosslinkers
Optimize crosslinking time to maximize signal while minimizing artifacts
Antibody selection and handling:
Use polyclonal antibodies for initial discovery and monoclonal antibodies for targeted validation
Test multiple antibodies targeting different epitopes of YGR161W-C
Employ stringent pre-clearing steps to remove non-specific interactions
Chromatin preparation refinements:
Optimize sonication conditions to achieve consistent fragment sizes (200-500bp)
Implement two-step chromatin shearing (enzymatic followed by sonication)
Use density gradient centrifugation to enrich for chromatin fractions
Controls and normalization:
Include input controls, IgG controls, and technical replicates
Implement spike-in normalization with exogenous chromatin
Use known binding regions as internal controls for experimental validation
Data analysis enhancements:
Apply multiple peak-calling algorithms and focus on consensus peaks
Implement batch correction for multi-sample experiments
Utilize machine learning approaches to distinguish true binding events from background
These strategies collectively address the major sources of variability in chromatin immunoprecipitation experiments and can significantly improve data quality.
Identifying proteins that interact with YGR161W-C at specific genomic regions requires sophisticated experimental approaches that combine protein interaction discovery with genomic localization:
Proximity-based labeling coupled with ChIP:
Express YGR161W-C fused to a proximity labeling enzyme (BioID or APEX2)
After activation, biotinylated proteins can be purified and identified by mass spectrometry
Follow with ChIP to confirm co-localization at specific genomic sites
Modified Calling Cards approach with dual tagging:
Develop a system where both YGR161W-C and potential interacting proteins are fused to complementary parts of the Sir4-Ty5 system
Interaction between proteins would lead to enhanced Ty5 integration near specific binding sites
Barcode analysis can identify which protein combinations interact at which genomic locations
Sequential ChIP (Re-ChIP):
Perform initial ChIP with YGR161W-C antibody
Re-immunoprecipitate using antibodies against suspected interaction partners
Analyze enriched regions to identify co-occupancy sites
Protein complex purification from specific genomic regions:
Adapt techniques like PICh (Proteomics of Isolated Chromatin segments) to isolate specific YGR161W-C-bound genomic regions
Identify co-purifying proteins by mass spectrometry
The table below compares these approaches across key parameters:
| Method | Spatial Resolution | Discovery Potential | Technical Difficulty | In vivo Relevance |
|---|---|---|---|---|
| Proximity Labeling + ChIP | Medium | High | Medium | High |
| Modified Calling Cards | High | Medium | High | High |
| Sequential ChIP | Medium | Low | Medium | Very High |
| PICh | Very High | High | Very High | High |
Selection of the appropriate method should be guided by the specific research question and available resources.
Statistical analysis of YGR161W-C binding site data requires consideration of both the biological context and technical aspects of the experimental methods used:
Peak calling optimization:
Significance assessment:
Implement appropriate multiple testing correction (Benjamini-Hochberg or Bonferroni)
Calculate false discovery rates based on control experiments
For Calling Cards method, be aware that approximately 49% false negative frequency at a 2.5% false positive rate has been observed in similar experiments with other transcription factors
Signal normalization strategies:
Normalize to input DNA and IgG controls
Apply quantile normalization for microarray data
Consider spike-in normalization for cross-sample comparisons
Integrative analysis:
Correlate binding data with expression profiles
Integrate with nucleosome positioning and histone modification data
Apply machine learning approaches to identify combinatorial binding patterns
When analyzing Calling Cards data specifically, be attentive to potential recombination events with endogenous Ty5 elements that can create false positives, particularly near telomeric regions .
Distinguishing direct from indirect DNA binding is crucial for accurately mapping transcription factor networks. For YGR161W-C, consider these approaches:
Motif analysis and validation:
Perform de novo motif discovery on YGR161W-C binding sites
Test direct binding to identified motifs using in vitro methods like EMSA
Compare binding strength at sites with and without the consensus motif
Structural considerations:
Analyze binding sites in the context of DNA shape and flexibility
Examine nucleosome positioning at binding sites (direct binding often occurs in nucleosome-free regions)
Experimental validation strategies:
Integrative genomic analysis:
Compare YGR161W-C binding with binding patterns of known co-factors
Sites bound by YGR161W-C alone are more likely to represent direct binding
Indirect binding sites often show complex occupancy patterns involving multiple factors
Protein domain mutations:
Engineer mutations in the DNA-binding domain of YGR161W-C
Compare binding profiles between wild-type and mutant proteins
Loss of binding at direct targets without affecting indirect targets
These approaches should be used in combination to build confidence in the classification of binding sites as direct or indirect.
YGR161W-C antibodies can serve as powerful tools in dissecting transcriptional regulatory networks through several sophisticated applications:
Temporal network mapping:
Use time-course ChIP experiments with YGR161W-C antibodies to capture dynamic binding changes during cellular responses
Correlate with expression data to identify direct regulatory relationships
Apply mathematical modeling to infer network dynamics and feedbacks
Perturbation-based network analysis:
Combine YGR161W-C binding data with systematic genetic perturbations
Use antibodies to track binding site redistributions after deleting specific network components
Identify condition-specific regulatory modules and their hierarchical organization
Multi-factor binding analysis:
Cross-species network conservation:
Apply YGR161W-C antibodies in comparative studies across yeast species
Identify evolutionarily conserved and divergent binding sites
Trace the evolution of regulatory networks involving YGR161W-C
This approach has already shown success with other transcription factors like Gal4 and Gcn4, where researchers discovered previously unidentified targets through methodologies like the Calling Cards technique .
The future of YGR161W-C research will likely be transformed by emerging technologies that complement or even replace traditional antibody-based approaches:
CRISPR-based genomic targeting:
CUT&RUN or CUT&Tag approaches using catalytically inactive Cas9 fused to YGR161W-C
Higher resolution mapping with reduced background compared to conventional ChIP
More efficient use of biological material with single-cell potential
Single-molecule tracking:
Live-cell imaging of fluorescently-tagged YGR161W-C to observe binding dynamics
Super-resolution microscopy to visualize the spatial organization of binding events
Correlation with chromatin accessibility in real-time
Protein-DNA interaction mapping in situ:
Techniques like FLASH that preserve nuclear architecture while mapping interactions
Integration with chromosome conformation capture methods (Hi-C) to understand 3D context
Multi-modal approaches connecting binding events with nuclear compartmentalization
Next-generation Calling Cards approaches:
Computational advancements:
Deep learning models trained on YGR161W-C binding data to predict binding in novel contexts
Integration of multi-omics data to build comprehensive regulatory models
Simulation of binding dynamics incorporating biophysical parameters
These emerging technologies will expand our understanding of YGR161W-C beyond simple binding site identification toward a dynamic, context-dependent view of its function.
Despite advances in studying DNA-binding proteins like YGR161W-C, several fundamental questions remain unanswered:
Condition-specific binding dynamics: How does YGR161W-C binding change across different stress conditions or developmental stages? The transient nature of certain regulatory interactions makes them difficult to capture with static methods.
Combinatorial regulatory logic: How does YGR161W-C function in concert with other transcription factors to achieve specific regulatory outcomes? The syntax of this combinatorial control remains poorly understood.
Mechanistic details of regulation: Does YGR161W-C primarily function as an activator, repressor, or both depending on context? What cofactors are required for its various functions?
Evolutionary conservation of function: To what extent are YGR161W-C binding sites and regulatory roles conserved across fungal species, and what does this reveal about core regulatory networks?
Non-canonical functions: Does YGR161W-C participate in processes beyond transcriptional regulation, such as chromosome organization or DNA repair?
These questions represent fruitful directions for researchers applying techniques like the Calling Cards method or ChIP-chip approaches to study YGR161W-C's role in genomic regulation .